Rolaids recall another setback for J&J

Johnson & Johnson faced another setback this week with the recall of more than 13 million packages of Rolaids antacids.

Johnson & Johnson faced another setback this week with the recall of more than 13 million packages of Rolaids antacids.

The recall includes 96 product lots following reports that metal and wood particles had been found in the softchews product, although McNeil Consumer Healthcare, a unit of Johnson & Johnson, said the risk of health problems is remote. The health products company has recalled more than 40 types of medicines in the last year.

The Wall Street Journal writes: "The Rolaids recall adds to the growing list of over-the-counter products recalled by J&J over the past year, hurting its sales and tarnishing its once-sterling reputation for product quality."

The company has taken a few public steps to address internal issues, including announcing earlier this year that it had reorganized its manufacturing unit and establishing a position focused on quality production, but it still faces an uphill battle to regain what was once a model reputation.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.